John Lauerman

2 pages

Health A new batch of COVID pills are in focus as daily life reopens. Here’s how the treatments work—and how well
BYJason Gale, John Lauerman, and others
February 15, 2022
Health Catching the common cold can help fend off COVID, study finds
BYTim Loh, John Lauerman, and others
January 10, 2022
Finance Johnson & Johnson shares jump as company follows GE and Toshiba in decision to split business apart
BYRiley Griffin, John Lauerman, and others
November 12, 2021
Health Merck says the U.S. will buy 1.4 million doses of its COVID-19 antiviral pill
BYJohn Lauerman and Bloomberg
November 9, 2021
Health FDA advisors unanimously back Johnson & Johnson COVID boosters for people 18 and older
BYJohn Lauerman and Bloomberg
October 15, 2021
Health What you need to know about severe reactions to COVID vaccines
BYJohn Lauerman, Jason Gale, and others
February 15, 2021

Health What to know about delaying second COVID vaccine shots as countries grapple with limited supplies
BYJohn Lauerman, Jason Gale, and others
January 26, 2021
Health Everything to know about allergic reactions to COVID vaccines
BYJohn Lauerman and Bloomberg
December 31, 2020
Health Pfizer to supply U.S. with 100 million more vaccine doses
BYJohn Lauerman, Riley Griffin, and others
December 23, 2020
Health AstraZeneca acquires rare-disease specialist Alexion in $39 billion deal
BYJohn Lauerman, James Paton, and others
December 13, 2020
Health Anthony Fauci tones down earlier criticism of U.K.’s Pfizer vaccine approval
BYJohn Lauerman, Mike Dorning, and others
December 4, 2020
Health For AstraZeneca’s COVID vaccine, less may be more—and that’s puzzling researchers
BYAngelica LaVito, John Lauerman, and others
November 25, 2020
Health U.S. government secures 100 million doses of Pfizer, BioNTech vaccine for $2 billion
BYJohn Lauerman and Bloomberg
July 22, 2020
International The earliest coronavirus vaccines may not protect you from getting infected
BYJohn Lauerman, James Paton, and others
June 15, 2020
Health What to know about a potential ‘second wave’ of COVID-19
BYJohn Lauerman and Bloomberg
June 12, 2020

1 - 15 of 24 results